SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Ortenzio Rocco A – ‘4’ for 3/19/20 re: Select Medical Holdings Corp.

On:  Friday, 3/20/20, at 5:15pm ET   ·   For:  3/19/20   ·   Accession #:  1179110-20-4032   ·   File #:  1-34465

Previous ‘4’:  ‘4’ on 1/14/20 for 1/6/20   ·   Next:  ‘4’ on 7/30/20 for 7/28/20   ·   Latest:  ‘4’ on 8/2/23 for 8/1/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/20/20  Ortenzio Rocco A                  4                      1:9K   Select Medical Holdings Corp.     Section16 Direct/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      3K 
                Securities by an Insider -- edgar.xml/3.6                        




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
ORTENZIO ROCCO A

(Last)(First)(Middle)
C/O SELECT MEDICAL HOLDINGS CORPORATION
4714 GETTYSBURG ROAD

(Street)
MECHANICSBURGPA17055

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
SELECT MEDICAL HOLDINGS CORP [ SEM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector 10% Owner
XOfficer (give title below) Other (specify below)
Vice Chairman and Co-Founder
3. Date of Earliest Transaction (Month/Day/Year)
3/19/20
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock 3/19/20 GV100,000D$0697,143D
Common Stock 3,250,000 (1)IBy the Rocco A. Ortenzio Descendants Trust (2)
Common Stock 2,000,000IBy the Rocco A. Ortenzio October 2019 GRAT (2)
Common Stock 4,421,450IBy the Rocco A. Ortenzio Revocable Trust dated 8/14/07, as amended (2)
Common Stock 30,601IBy Select Investments III, L.P. (2)
Common Stock 16,182IBy Select AP Investors, L.P. (2)
Common Stock 10,000IBy spouse (2)
Common Stock 56,669IBy the Rocco A. Ortenzio 2014 Trust for Robert A. Ortenzio (2)
Common Stock 56,668IBy the Rocco A. Ortenzio 2014 Trust for Martin J. Ortenzio (2)
Common Stock 56,668IBy the Rocco A. Ortenzio 2014 Trust for John M. Ortenzio (2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
(1)  100,000 shares were previously owned by, and contributed by, Rocco A. Ortenzio to the Rocco A. Ortenzio Descendants Trust.
(2)  The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ Michael E. Tarvin, as attorney-in-fact 3/20/20
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Code:
    G    Bona fide gift.

Top
Filing Submission 0001179110-20-004032   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 6:58:42.1am ET